Skip to Main Content

Author Details

David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
2005
75
25
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36791207An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.Sci Transl Med2023
38011121Enteric pharmacokinetics of monomeric and multimeric camelid nanobody single-domain antibodies.PLoS One2023
37609210Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria.Res Sq2023
36965482Evaluation of repRNA vaccine for induction and in utero transfer of maternal antibodies in a pregnant rabbit model.Mol Ther2023
36847573Coimmunization with Preerythrocytic Antigens alongside Circumsporozoite Protein Can Enhance Sterile Protection against <i>Plasmodium</i> Sporozoite Infection.Microbiol Spectr2023
36862518Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.J Clin Invest2023
36226962Persistent Nonviral Plasmid Vector in Nasal Tissues Causes False-Positive SARS-CoV-2 Diagnostic Nucleic Acid Tests.Microbiol Spectr2022
35841132Optimization and use of near infrared imaging to guide lymph node collection in rhesus macaques (Macaca mulatta).J Med Primatol2022
35793394Germinal center activity and B cell maturation are associated with protective antibody responses against Plasmodium pre-erythrocytic infection.PLoS Pathog2022
36001680A genetically engineered <i>Plasmodium falciparum</i> parasite vaccine provides protection from controlled human malaria infection.Sci Transl Med2022
36103857Freshly remodeled and ready to fight malaria.Immunity2022
33472907Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.J Immunol2021
33851164Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.bioRxiv2021
33851160A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2.bioRxiv2021
33842901Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.Cell Rep Med2021
33857426Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapses.Cell Host Microbe2021
33658998Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.Front Immunol2021
34914685Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.PLoS Biol2021
34874007Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.Elife2021
34868082Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.Front Immunol2021
34788328Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.PLoS One2021
34549725Determinants of brain swelling in pediatric and adult cerebral malaria.JCI Insight2021
34781736Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.mBio2021
34688034Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.EBioMedicine2021
34348141Antibody interference by a non-neutralizing antibody abrogates humoral protection against Plasmodium yoelii liver stage.Cell Rep2021
33961680Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques.PLoS Pathog2021
34312615Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike.Res Sq2021
34194331A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.Front Pharmacol2021
32470041Oral Immunization with HIV-1 Envelope SOSIP trimers elicits systemic immune responses and cross-reactive anti-V1V2 antibodies in non-human primates.PLoS One2020
32577669Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay.medRxiv2020
32798222Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.J Infect Dis2020
32739836A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage Infection.iScience2020
32121092Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression.Antibodies (Basel)2020
30523691A Tandem Mass Spectrometry Sequence Database Search Method for Identification of O-Fucosylated Proteins by Mass Spectrometry.J Proteome Res2019
29253313Plasmodium yoelii S4/CelTOS is important for sporozoite gliding motility and cell traversal.Cell Microbiol2018
29884783Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.Nat Commun2018
29933399B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.PLoS Pathog2018
30547015The Micronemal Plasmodium Proteins P36 and P52 Act in Concert to Establish the Replication-Permissive Compartment Within Infected Hepatocytes.Front Cell Infect Microbiol2018
30566528Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.PLoS One2018
30333026A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages.Malar J2018
29743474A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.Nat Commun2018
29544097Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection.Cell Host Microbe2018
29367469cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses.JCI Insight2018
27509243Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses.J Acquir Immune Defic Syndr2017
28334821In vivo cleavage specificity of Trypanosoma brucei editosome endonucleases.Nucleic Acids Res2017
28277097Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection.Expert Rev Vaccines2017
29107642Linking EPCR-Binding PfEMP1 to Brain Swelling in Pediatric Cerebral Malaria.Cell Host Microbe2017
28554543A method for the isolation and characterization of functional murine monoclonal antibodies by single B cell cloning.J Immunol Methods2017
26944928Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.J Immunol2016
28009289Blood Stage Malaria Disrupts Humoral Immunity to the Pre-erythrocytic Stage Circumsporozoite Protein.Cell Rep2016
  • 1 - 50 of 75

Recommended Authors

Carolina Lucas
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Laura A VanBlargan
Washington University School of Medicine
Career Start Year 2013
Number of shared co-authors 4
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 2
Natalia A Kuzmina
University of Texas Medical Branch, USA Galveston National Laboratory
Career Start Year 2012
Number of shared co-authors 5
Thiago Y Oliveira
The Rockefeller University
Career Start Year 2010
Number of shared co-authors 9
Ujjwal Rathore
University of California san francisco
Career Start Year 2010
Number of shared co-authors 2
Goran Bajic
Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 6
Jack S Richards
ZIP Diagnostics Pty Ltd.
Career Start Year 2006
Number of shared co-authors 1
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 0
Pavlo Gilchuk
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 3
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 3
Kristina De Paris
University of North Carolina at Chapel Hill Chapel Hill
Career Start Year 2004
Number of shared co-authors 0
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 3
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 3
Bjoern Peters
University of Washington School of Medicine
Career Start Year 2002
Number of shared co-authors 7
Mansun Law
The Scripps Research Institute
Career Start Year 1998
Number of shared co-authors 2
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 1
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 4
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 8
Cynthia A Derdeyn
University of Washington
Career Start Year 1995
Number of shared co-authors 2
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 7
Leonard Moise
EpiVax Inc.
Career Start Year 1991
Number of shared co-authors 0
Anne S De Groot
University of Georgia
Career Start Year 1989
Number of shared co-authors 0
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 0
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 4
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Career Start Year 1984
Number of shared co-authors 10
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 14
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 13
Timothy R Fouts
Profectus BioSciences Inc.
Career Start Year 1981
Number of shared co-authors 1
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 8

Collaborators

Vladimir Vigdorovich
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers 23
Nicholas Dambrauskas
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers 20
Leonidas Stamatatos
Co-authored papers 15
John D Aitchison
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers 6
Alexis Kaushansky
Seattle Children's Research Institute, University of Washington
Co-authored papers 4
Fred D Mast
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers 4
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 3
Christopher B Wilson
Drukier Institute for Children's Health
Co-authored papers 3
Byung Park
Oregon Health & Science University
Co-authored papers 3
Michael P Rout
The Rockefeller University
Co-authored papers 2
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 2
David C Montefiori
Co-authored papers 2
Yiska Weisblum
Rockefeller University
Co-authored papers 2
Theodora Hatziioannou
The Rockefeller University
Co-authored papers 2
Jason S Debley
Seattle Children's Hospital, University of Washington
Co-authored papers 2
Tanmoy Sanyal
University of California san francisco
Co-authored papers 2
Peter C Fridy
The Rockefeller University
Co-authored papers 2
Kelly R Molloy
The Rockefeller University
Co-authored papers 2
Nadia Arang
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Brian T Chait
The Rockefeller University
Co-authored papers 2
Erica Y Jacobs
The Rockefeller University, St John's University
Co-authored papers 2
Malina A Bakowski
a division of The Scripps Research Institute La Jolla
Co-authored papers 2
Junjie Wang
The Rockefeller University
Co-authored papers 2
Natalia E Ketaren
The Rockefeller University
Co-authored papers 2
Robert L Moritz
Institute for Systems Biology
Co-authored papers 2
Case W McNamara
a division of The Scripps Research Institute La Jolla
Co-authored papers 2
Celia C LaBranche
Co-authored papers 2
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 2
Release 1.2